Ginsenoside Rb1 Protects Neonatal Rat Cardiomyocytes from Hypoxia/Ischemia Induced Apoptosis and Inhibits Activation of the Mitochondrial Apoptotic Pathway

Abstract

Aim. To investigate the effect of Ginsenoside Rb1 (GS-Rb1) on hypoxia/ischemia (H/I) injury in cardiomyocytes in vitro and the mitochondrial apoptotic pathway mediated mechanism. Methods. Neonatal rat cardiomyocytes (NRCMs) for the H/I groups were kept in DMEM without glucose and serum, and were placed into a hypoxic jar for 24 h. GS-Rb1 at concentrations from 2.5 to 40 µM was given during hypoxic period for 24 h. NRCMs injury was determined by MTT and lactate dehydrogenase (LDH) leakage assay. Cell apoptosis, ROS accumulation, and mitochondrial membrane potential (MMP) were assessed by flow cytometry. Cytosolic translocation of mitochondrial cytochrome c and Bcl-2 family proteins were determined by Western blot. Caspase-3 and caspase-9 activities were determined by the assay kit. Results. GS-Rb1 significantly reduced cell death and LDH leakage induced by H/I. It also reduced H/I induced NRCMs apoptosis induced by H/I, in accordance with a minimal reactive oxygen species (ROS) burst. Moreover, GS-Rb1 markedly decreased the translocation of cytochrome c from the mitochondria to the cytosol, increased the Bcl-2/ Bax ratio, and preserved mitochondrial transmembrane potential (ΔΨm). Its administration also inhibited activities of caspase-9 and caspase-3. Conclusion. Administration of GS-Rb1 during H/I in vitro is involved in cardioprotection by inhibiting apoptosis, which may be due to inhibition of the mitochondrial apoptotic pathway.

Estrogen receptor‐β of microglia underlies sexual differentiation of neuronal protection via ginsenosides in mice brain

“…Microglial apoptosis is more detrimental than microglial activation in response to inflammatory challenge . The neuroprotective effects of Rb1 have been confirmed in several studies; however, the mechanism of Rb1 interacting with microglia is largely unknown . Thus, we evaluated the ability of Rb1 to affect microglial apoptosis in cultured BV2 microglial cells infected with S. pneumoniae .…”

“…28 The neuroprotective effects of Rb1 have been confirmed in several studies; however, the mechanism of Rb1 interacting with microglia is largely unknown. 29,30 Thus, we evaluated the ability of Rb1 to affect microglial apoptosis in cultured BV2 microglial cells infected with S. pneumoniae. Rb1 treatment significantly increased the expression of ERβ, BDNF ( Figure 3A notably, these mRNA changes occurred prior to significant alterations in protein.…”

Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways

“…However, both the anti-apoptotic and antiproliferative capacities of ginsenoside Rb1 on different cell types under diverse pathological conditions were reported previously. For instance, ginsenoside Rb1 reduced ischemia/reperfusion-induced apoptosis of cardiomyocytes and neurocytes [39,40], while the anticancer property of ginsenoside Rb1 was exhibited through its inhibition of melanoma cell proliferation [41]. Li et al [42] demonstrated that ginsenoside Rb1 inhibited FBS-induced proliferation of rat aortic smooth muscle cells.…”

Glycitein induces reactive oxygen species‐dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF‐κB pathway in human gastric cancer cells

“…The mitochondrial apoptotic pathway included loss of ΔΨm and changes in Bcl-2/Bax ratio, which are followed by activation of caspase-3. Once caspase-3 is in action, apoptotic cell death is inevitable (Ly, Grubb, & Lawen, 2003;Yan et al, 2014). The Bcl-2 family, including Bcl-2 and Bax, is the major protein that regulates the mitochondrial pathway by controlling the permeabilization of mitochondrial membrane (Tang et al, 2013;Tomiyama et al, 2010).…”